Saint-Gobain Acquires Disposable Plastics Manufacturer

Article

Saint-Gobain Performance Plastics Corporation (Aurora, OH) has acquired the assets of J & J Scientific Products, Inc. (Tampa, FL), a manufacturer of disposable plastic products for the biopharmaceutical market.

Saint-Gobain Performance Plastics Corporation (Aurora, OH) has acquired the assets of J & J Scientific Products, Inc. (Tampa, FL), a manufacturer of disposable plastic products for the biopharmaceutical market. Terms of the acquisition were not disclosed.

J & J will be integrated into Saint-Gobain’s Fluid Systems division. At its single manufacturing location in Tampa, J & J makes manifold systems, flask closure systems, flask and bottle assemblies, and tubing end assemblies that are used by biopharmaceutical manufacturers in research, development, and production.

J & J release

Recent Videos
Related Content
Bioreactor. Cultivation of microorganisms in the bioreactor. Laboratory fermenter. Microbial fermentation. The creation of drugs. Microbiology. Biotech industry. Pharmacology. | Image Credit: © Grispb - stock.adobe.com

Aragen to Commence GMP Manufacturing at India Biologics Facility in July 2025

Patrick Lavery
June 16th 2025
Article

The company’s successful completion of facility and equipment qualifications gives it another biologics manufacturing option alongside its United States campus in Morgan Hill, Calif.

Podcast: Alternative Drug Delivery Methods for Biologics: Where Are We At?

Podcast: Alternative Drug Delivery Methods for Biologics: Where Are We At?

Feliza Mirasol
September 27th 2024
Podcast

This podcast explores the challenges of and the progress made so far by the biopharma industry toward alternative drug delivering methods for biologic drugs.

Abstract logo featuring a sleek, blue arrow curving around a circular element, suggesting growth and speed. Motion blur effect adds dynamism. | Image Credit: ©joeycheung – Stock.Adobe.com

The Challenges of Downstream Operations in the World of Continuous Biomanufacturing

Jeffery Odum
June 8th 2025
Article

A continuous biomanufacturing platform can process higher/lower quantities of a drug as needed and allow manufacturers to respond to changing markets.

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Felicity Thomas
May 25th 2023
Podcast

Hanns-Christian Mahler and Andrea Allmendinger from ten23 health will discuss some key aspects of biologic drug development and manufacturing.

PCI Pharma Services office in Mississauga, Ontario, Canada on September 19, 2020. PCI is an expert in pharmaceutical and biopharmaceutical supply chain solutions. | Image Credit: © JHVEPhoto - stock.adobe.com

PCI Pharma Services Introduces New Manufacturing Facility Ahead of BIO 2025

Patrick Lavery
June 5th 2025
Article

The facility is on the company’s Bedford, NH campus, where another existing building will be repurposed into a Development Center of Excellence.

A lab technician in protective gear operates a tablet displaying a green checkmark in a high-tech pharmaceutical laboratory. | Image Credit: © greenbutterfly - stock.adobe.com

Companies Reveal Their Next Moves in Manufacturing

Patrick Lavery
May 29th 2025
Article

In discussions at INTERPHEX 2025, company representatives seized upon several common themes, most notably safety, sustainability, and the increasing utility of automation.

© 2025 MJH Life Sciences

All rights reserved.